INO80 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.282400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.635010E-01
Normal-vs-Stage2
8.009500E-02
Normal-vs-Stage3
3.591700E-02
Normal-vs-Stage4
4.824400E-01
Stage1-vs-Stage2
5.755800E-01
Stage1-vs-Stage3
1.311970E-02
Stage1-vs-Stage4
7.482200E-01
Stage2-vs-Stage3
4.677900E-02
Stage2-vs-Stage4
4.400200E-01
Stage3-vs-Stage4
7.888400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.487800E-02
Normal-vs-AfricanAmerican
2.238600E-01
Normal-vs-Asian
9.827700E-02
Caucasian-vs-AfricanAmerican
7.518800E-01
Caucasian-vs-Asian
2.939200E-01
AfricanAmerican-vs-Asian
4.336400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.046000E-02
Normal-vs-Female
7.725700E-02
Male-vs-Female
4.571200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.879600E-01
Normal-vs-Age(41-60Yrs)
1.508440E-01
Normal-vs-Age(61-80Yrs)
5.114300E-02
Normal-vs-Age(81-100Yrs)
1.435620E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.393200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.439600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.264600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.432390E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.988500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.422200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.270000E-02
Normal-vs-Daily Drinker
1.625040E-01
Normal-vs-Weekly Drinker
1.065770E-01
Normal-vs-Occasional Drinker
8.041600E-02
Normal-vs-Social Drinker
5.900000E-02
Non Drinker-vs-Daily Drinker
5.408800E-01
Non Drinker-vs-Weekly Drinker
9.734800E-01
Non Drinker-vs-Occasional Drinker
2.012400E-01
Non Drinker-vs-Social Drinker
3.889000E-01
Daily Drinker-vs-Weekly Drinker
6.579200E-01
Daily Drinker-vs-Occasional Drinker
5.937600E-01
Daily Drinker-vs-Social Drinker
8.517400E-01
Weekly Drinker-vs-Occasional Drinker
3.045400E-01
Weekly Drinker-vs-Social Drinker
4.904200E-01
Occasional Drinker-vs-Social Drinker
6.925000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.601900E-02
Normal-vs-Grade 2
6.640000E-03
Normal-vs-Grade 3
5.218100E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.438400E-02
Grade 1-vs-Grade 3
1.547820E-02
Grade 1-vs-Grade 4
8.601900E-02
Grade 2-vs-Grade 3
1.762410E-01
Grade 2-vs-Grade 4
6.640000E-03
Grade 3-vs-Grade 4
5.218100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.398400E-02
Normal-vs-NonDiabetic
5.938300E-02
Diabetic-vs-NonDiabetic
2.798600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.850100E-02
Normal-vs-NoPancreatitis
6.165900E-02
Pancreatitis-vs-NoPancreatitis
9.521200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.765700E-02
Normal-vs-N1
9.609900E-02
N0-vs-N1
2.693400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.406200E-01
Normal-vs-TP53-NonMutant
2.101200E-01
TP53-Mutant-vs-TP53-NonMutant
1.830570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
